NBIX - NEUROCRINE BIOSCIENCES INC
128.13
-1.510 -1.178%
Share volume: 903,600
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$129.64
-1.51
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-01-2024 | 08-01-2024 | 10-30-2024 | 02-10-2025 | 05-05-2025 | 07-30-2025 | 10-28-2025 | 02-11-2026 | |
| Total revenue | 515.300 M | 590.200 M | 622.100 M | 627.700 M | 572.600 M | 687.500 M | 794.900 M | 805.500 M | |
| Cost of revenue | 7.500 M | 9.200 M | 8.000 M | 9.300 M | 9.200 M | 11.300 M | 14.000 M | 17.600 M | |
| Gross profit | 507.800 M | 581.000 M | 614.100 M | 618.400 M | 563.400 M | 676.200 M | 780.900 M | 787.900 M | |
| 14.42% | 5.70% | 0.70% | -8.89% | 20.02% | 15.48% | 0.90% | |||
| Operating expenses | 408.500 M | 435.600 M | 430.300 M | 476.400 M | 539.800 M | 530.600 M | 541.900 M | 577.000 M | |
| Selling general and admin | 243.100 M | 242.000 M | 234.300 M | 287.800 M | 276.500 M | 286.300 M | 291.600 M | 301.800 M | |
| Research and development | 165.400 M | 193.600 M | 196.000 M | 188.600 M | 263.300 M | 244.300 M | 250.300 M | 275.200 M | |
| Total expenses | 408.500 M | 435.600 M | 430.300 M | 476.400 M | 539.800 M | 530.600 M | 541.900 M | 577.000 M | |
| 6.63% | -1.22% | 10.71% | 13.31% | -1.70% | 2.13% | 6.48% | |||
| Operating income | 99.300 M | 145.400 M | 183.800 M | 142.000 M | 23.600 M | 145.600 M | 239.000 M | 210.900 M | |
| Ebit | 12.200 M | 125.500 M | 166.900 M | 228.800 M | -7.000 M | 138.900 M | 269.600 M | 213.600 M | |
| Pretax income | 34.500 M | 98.600 M | 190.300 M | 162.600 M | 14.700 M | 159.500 M | 291.800 M | 239.400 M | |
| 185.80% | 93.00% | -14.56% | -90.96% | 985.03% | 82.95% | -17.96% | |||
| Income tax | -8.900 M | 33.600 M | 60.500 M | 59.500 M | 6.800 M | 52.000 M | 82.300 M | 85.700 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 43.400 M | 65.000 M | 129.800 M | 103.100 M | 7.900 M | 107.500 M | 209.500 M | 153.700 M | |
| 49.77% | 99.69% | -20.57% | -92.34% | 1,260.76% | 94.88% | -26.63% |